Select Page

A curated selection of EPHA’s mentions in worldwide media outlets.

2017

ACCESS TO MEDICINE IS NOW A MATTER SOCIAL JUSTICE AND COHESION

HEALTH DAILY

21 December 2017

Interview with Yannis Natsis, Policy Manager for Universal Access & Affordable Medicines, European Public Health Alliance (EPHA) (Greek language)


NEW REPORT: MOST INFANT FORMULA CLAIMS NOT BASED ON SCIENCE; MOSTLY MARKETING RESEARCH

HUFFPOST

14 December 2017

The investigative report by The Changing Markets Foundation, Globalization Monitor, SumOfUs and the European Public Health Alliance (EPHA) calls for a comprehensive overhaul of infant formula products and their regulation so that only claims based on unequivocal scientific advice are used.


SMOKE AND MIRRORS OR CLEAR COMMUNICATION? INDUSTRY CLASHES OVER EVOLVED NUTRITION LABENEW REPORT: MOST INFANT FORMULA CLAIMS NOT BASED ON SCIENCE; MOSTLY MARKETING RESEARCH

FOOD NAVIGATOR

1 December 2017

The European Consumer Organisation (BEUC), the European Heart Network (EHN) and the European Public Health Alliance (EPHA) issued a joint statement  yesterday both praising and condemning the ENL. […] “Such labelling must be understood at a glance by consumers and allow straightforward comparison between products,” they wrote.


Project Censored 2017, The missing stories, and exposing patterns of what’s missed

SYRACUSE NEWTIMES

29 November 2017

“The EPHA assessment recommended five responses that major purchasers of medicines could implement to help stop antibiotic pollution. Among these recommendations are blacklisting pharmaceutical companies that contribute to the spread of superbugs through irresponsible practices, and promoting legislation to incorporate environmental criteria into the industry’s good manufacturing practices.”


Europe’s Child Poverty Hot Spots

TOL

21 November 2017

 


EU universal healthcare system in deep crisis, report shows

NEWEUROPE

10 November 2017

“There are big holes in terms of providing universal access to EU healthcare, where our commitments really stuck up and not translated into policy action. Sometimes, an entire ethnic group like Bulgarian and Romanian Roma which accounts up to nine million people is excluded from receiving any medical assistance,” Nina Renshaw, Secretary-General at European Public Health Alliance.


Infant formula makers accused of milking parent’s feeding concerns

NUTRAingredients.com

07 November 2017

However, the investigation involving the Changing Markets Foundation, Globalization Monitor, SumOfUs and the European Public Health Alliance (EPHA), went further afield looking at the market for infant formula in China and Hong Kong.


Underreported, The top 10 stories of the year that mainstream media ignored

Newsreview.com

02 November 2017

“After bacteria in the environment become resistant, they can exchange genetic material with other germs, spreading antibiotic resistance around the world, according to an assessment issued by the European Public Health Alliance, which served as the basis for Davies’ news report,” Project Censored explained. One strain of drug-resistant bacterium that originated in India in 2014 has since spread to 70 other countries.


Patients: ‘Think carefully’ before questioning orphan drugs’ incentives

EURACTIV

12 October 2017

Yannis Natsis, Policy Manager at the European Public Health Alliance (EPHA), said the problem with orphan drugs is the growing number of medicines obtaining the orphan drug designation.


The future of health is discussed in Geneva

LE TEMPS

10 October 2017

Original title: Le futur de la santé se discute à Genève


Project Censored The missing stories and the patterns they expose

North Coast Journal

05 October 2017

“After bacteria in the environment become resistant, they can exchange genetic material with other germs, spreading antibiotic resistance around the world, according to an assessment issued by the European Public Health Alliance, which served as the basis for Davies’s news report,” Project Censored explained.”


British Medical Journal (BMJ) presents ground-breaking study at “Medicines: New Game, New Rules” session at Gastein

EUbusiness

05 October 2017

“The study was presented at the European Health Forum Gastein 2017 during a session titled “Medicines: new game, new rules. Pathways for better and affordable medicines” organised by the European Public Health Alliance (EPHA), the European Public Health Association (EUPHA) and Open Society Foundation (OSF) by authors Dr Courtney Davis and Dr Ajay Aggarwal.”


Drug lobby’s market protections, Health care campaigners, NGOs and some EU countries hope for legislative changes to scale back protections for the pharmaceutical industry, but any changes will take years.

POLITICO

05 October 2017

“The June 2016 Council conclusions started a discussion, which will not end when this study is completed,” said Yannis Natsis, policy manager for universal access and affordable medicines at the European Public Health Alliance. “A follow-up study might be envisaged to examine in depth the cost of these exclusivities,” he added.


The Top 10 underreported stories of 2016-17 

Colorado Springs independent

04 October 2017

“After bacteria in the environment become resistant, they can exchange genetic material with other germs, spreading antibiotic resistance around the world, according to an assessment issued by the European Public Health Alliance, which served as the basis for Davies’ news report. One strain of drug-resistant bacterium that originated in India in 2014 has since spread to 70 other countries.”


The Censored List, Why are these 10 important stories so underreported?

SALT LAKE City Weekly

04 October 2017

“After bacteria in the environment become resistant, they can exchange genetic material with other germs, spreading antibiotic resistance around the world, according to an assessment issued by the European Public Health Alliance, which served as the basis for Davies’ news report,” Project Censored explained. One strain of drug-resistant bacterium that originated in India in 2014 has since spread to 70 other countries.”


Project Censored: The Top 25 Stories You Probably Missed This Year 

SOURCE Weekly

04 October 2017

“The EPHA assessment recommended five responses that major purchasers of medicines could implement to help stop antibiotic pollution. Among these recommendations are blacklisting pharmaceutical companies that contribute to the spread of superbugs through irresponsible practices, and promoting legislation to incorporate environmental criteria into the industry’s good manufacturing practices.”


eHealth Meets Public Health

Linkedin

20 September 2017

In May this year, the European Public Health Alliance (EPHA) published a report on the use of digital solutions for health and disease management


” Vote for the law that will save 2,000 lives annually “

Jurnalul.ro

14 September 2017

Original title: “Votaţi legea care va salva 2.000 de vieţi anual”


Call to International Action to Break Deadlock on Chronic Diseases Crisis | EPHA Annual Conference 2017

EUbusiness

11 September 2017

“Policy is where the obesity crisis will be solved, plain and simple,” said the WHO’s Dr Sandro Demaio opening the 2017 European Public Health Alliance (EPHA) Annual Conference “Make Health YOUR Business”, which focused on breaking the deadlock to action to curb the growth of chronic diseases.


Should Europe follow in UK footsteps with childhood obesity strategy?

FOODnavigator.com

24 August 2017

“Without wanting to pass judgment on whether the UK strategy is up to the challenge of fighting child obesity or not, I think the principle of introducing a strategy should act as inspiration for other European countries,” said Nikolai Pushkarev, policy coordinator for food, drink and agriculture at the European Public Health Alliance.


Expensive medicine means people die

Forum Alpbach

22 August 2017

Yannis Natsis, Policy Manager for Universal Access and Affordable Medicines at the European Public Health Alliance (EPHA), told the Alpbach Media Academy on Tuesday that due to austerity and financial challenges, many European countries are no longer as rich as they used to be.


UK’s childhood obesity strategy – an EU blueprint?

EUobserver

18 August 2017

Nikolai Pushkarev, policy coordinator for food, drink and agriculture at the European Public Health Alliance, believes more national obesity strategies are on the way. “Our hope and expectations are that they will be designed to deliver,” he told EUobserver.


Mooovin’ away from ‘bargain-bin’ UK: Raising livestock standards post-Brexit

FOODnavigator

31 July 2017

Along with FoE and the Eating Better alliance, contributions from WWF-UK, Compassion in World Farming, Sustain and the European Public Health Alliance detail aspects of the EU Common Agricultural Policy (CAP) that they say are outdated and not fit for purpose.


EU AMR action plan ignores pharma pollution, say NGOs

in-PharmaTechnologist.com

04 July 2017

However, the European Public Health Alliance (EPHA), comprised of non-government organisations, patient groups, health professionals and disease groups, said the Act fails to address the problem of pollution generated by drug and active pharmaceutical ingredient (API) firms which have been blamed for contributing to the spread of AMR.


Europe plans action on superbugs, some doubt over implementation

ThePharmaLetter

04 July 2017

 


Commission seeks ‘measurable goals’ in new antimicrobial resistance plan

EURACTIV

29 June 2017

Contacted by EURACTIV.com, Sascha Marschang of the European Public Health Alliance (EPHA) stressed that while developing indicators is obviously a positive thing, “measurable goals” could mean many things.


Antibiotic resistance is the best case for ‘more Europe’

EURACTIV

28 June 2017

A new EPHA study, based on interviews with experts from healthcare practice and policy in Romania identifies needs for structured long-term support which transcends political terms of office, in the form of European expertise, targets and funding to reduce antibiotic over-consumption, training for health workers on how to more effectively control infections and use rapid diagnostic tests, lab equipment, set up of isolation units and public information campaigns.


Global regulators align to assist antibiotic development in AMR climate

in-PharmaTechnologist.com

13 June 2017

European health organisations, including the European Public Health Alliance (EPHA) and Health Action International, are also in discussions regarding the threat of antimicrobial resistance.


Opinion Europe can provide citizens with better food

FOODLOG

09 June 2017

Original title: Opinie Europa kan burgers beter eten verschaffen.


POLITICO Pro Brussels Influence: Numbers game — Taking on Twitter — Küneralp to Kreab

POLITICO

07 June 2017

 


The creeping privatisation of healthcare. Problematic EU policies and the corporate lobby push

Corporate Europe Observatory

02 June 2017

As part of her research for this article, Rachel Tansey did background interviews with, and would like to thank, Jan Willem Goudriaan and Mathias Maucher (European Federation of Public Service Unions), Jane Lethbridge (Public Services International Research Unit, University of Greenwich), Rita Baeten (European Social Observatory), Zoltán Massay-Kosubek (European Public Health Alliance) and Sonia Roschnik (Health Care Without Harm Europe). Views in this article do not necessarily reflect those of interviewees.


Solving the drug development program

Pharmafocus

26 May 2017

 


MEPs water down rules on junk food advertising to kids

FOODnavigator

22 May 2017

Rules on product placement have been “relaxed”, said Nikolai Pushkarev, policy coordinator at the European Public Health Alliance (EPHA).


An open letter to ministers on the audiovisual directive

EUobserver

22 May 2017

 


Audiovisual bill falls short in battle against childhood obesity

EUobserver

15 May 2017

Others told of a similar story. “Our starting position was pretty radical,” admitted Nikolai Pushkarev, policy coordinator at the European Public Health Alliance (EPHA), “but what we’ve ended up with is a governance failure.”


AIR POLLUTION, EUROPE’S LARGEST ENVIRONMENTAL HEALTH HAZARD

EU OBSERVER

3 May 2017

“Financial incentives are vital to ensure the proper implementation of EU law. Member states should not regard implementing policies as costs but rather as an investment,” EPHA policy coordinator Zoltan Massay-Kosubek told EUobserver.


FDA APPROVES SOVALDI AND HARVONI FOR PEDRIATIC HEPATITIS C PATIENTS

HEPATITIS NEWS TODAY

10 April 2017

In other related news, the European Public Health Alliance (EPHA) plus 30 other civil society organizations from 17 European countries recently filed a coordinated patent opposition on Sovaldi and Harvoni contesting the high prices of the drugs. Results of this initiative might translate into more accessible treatments for European patients.


TREINTA ORGANIZACIONES SE UNEN PARA REVOCAR EL MONOPOLIO DEL FÀRMACO DE LA HEPATITIS C

ELDIARIO.ES

04 April 2017

Un grupo de más de 30 organizaciones –entre las que están Médicos Sin Fronteras (MSF), Médicos del Mundo, Salud por Derecho o la Alianza Europea para la Salud Pública– sehanunido para intentarque la Oficina Europea de Patentes revoque la licenciaquepermite a la empresa farmacéutica Gilead mantener el monopoliosobre el medicamento para la hepatitis C, sofosbuvir, cuyotratamientotiene un precioquerondalos 25.000 euros en España.


MÉDICINS DU MONDE S’OPPOSE À UN AUTRE BREVET SUR LE SOFOSBUVIR : 30 ONG ET ASSOCIATIONS DANS 17 PAYS NOUS REJOIGNENT

MÉDICINES DU MONDE

27 March 2017

Notre précédente action a ouvert la voie :aujourd’hui, 30 ONG dans 17 pays semobilisent. Dix sections du réseau international de Médecins du Monde en Europe,13 sections de Médecins Sans Frontières en Europe et 5 associations nationales et l’Alliance européenne pour la santé publiquerejoignentcette seconde opposition au brevet.


UNA TREINTENA DE ORGANIZACIONES DESAFÍAN LA PATENTE DEL MEDICAMENTO CONTRA LA HEPATITIS C

ACTUALIDAD HUMANITARIA

29 March 2017

A día de hoy, 30 organizaciones no gubernamentales y de la sociedad civil de 17 países europeos están comprometidas en este nuevo procedimiento. 10 delegaciones de la red internacional de Médicos del Mundo y 13 de la red de Médicos sin Fronteras en Europa, 5 organizacionessocialesnacionales y la Alianza Europea para la Salud Pública seunena estanueva oposición. En España, Médicos del Mundo y Salud por Derecho son las dos entidadesquese oponen a la patente.


SOFOSBUVIR: MÉDICOS DEL MUNDO RECURRE LA PATENTE EN LA UNIÓN EUROPEA

PERIODISTAS EN ESPAÑOL.COM

29 March 2017

Nuestro procedimiento anterior ha allanado el camino. A día de hoy, 30 organizaciones no gubernamentales y de la sociedad civil de 17 países europeos están comprometidas en este nuevo procedimiento. 10 delegaciones de la red internacional de Médicos del Mundo y 13 de la red de Médicos sin Fronteras en Europa, 5 organizaciones sociales nacionales y la Alianza Europea para la Salud Pública se unen a esta nueva oposición. En España, Médicos del Mundo y Salud por Derecho son las dos entidades que se oponen a la patente.


EUROPEAN PUBLIC HEALTH ALLIANCE JOINS PATENT OPPOSITION FOR HCV TREATMENT

HEPATITIS NEWS TODAY

28 March 2017

The European Public Health Alliance (EPHA) is one of 30 civil society organizations from 17 European countries to file a coordinated patent opposition on sofosbuvir with the European Patent Office (EPO). Sofosbuvir is a hepatitis C therapy sold under the brand name Sovaldi among others.


PIDEN FIN AL MONOPOLIO SOBRE UN MEDICAMENTO CLAVE PARA LA HEPATITIS C

PMFARMA

28 March 2017

30 organizaciones no gubernamentales y de la sociedad civil de 17 países europeos han presentado una oposición a la patente de Sovaldi (sofosbuvir) ante la Oficina Europea de Patentes (EPO). Entre ellas, 10 delegaciones de la red internacional de Médicos del Mundo, 13 de la red de Médicos sin Fronteras en Europa, cinco organizaciones sociales nacionales (entre ellas la española Salud por Derecho) y la Alianza Europea para la Salud Pública (EPHA).


MÉDICINS DU MONDE S’OPPOSE À UN AUTRE BREVET SUR LE SOFOSBUVIR : 30 ONG ET ASSOCIATIONS DANS 17 PAYS NOUS REJOIGNENT

MÉDICINES DU MONDE

27 March 2017

Notre précédente action a ouvert la voie : aujourd’hui, 30 ONG dans 17 pays se mobilisent. Dix sections du réseau international de Médecins du Monde en Europe,13 sections de Médecins Sans Frontières en Europe et 5 associations nationales et l’Alliance européenne pour la santé publique rejoignent cette seconde opposition au brevet.


AIDES DÉPOSE UNE OPPOSITION AU BREVET DU SOVALDI

SERONET

27 March 2017

Ce même jour, onze sections de Médecins du Monde et treize de Médecins sans Frontières déposent également une opposition sur ce brevet ainsi que des organisations non gouvernementales européennes mobilisées pour l’accès aux traitements (2).
(2) : European public health alliance (EPHA), Just treatment (Grande-Bretagne), Salud por Derecho (Espagne), Praksis (Greece), Access to medicines (Ireland).


HÉPATITE C : NOUVELLE OFFENSIVE CONTRE LE BREVET C

LIBÉRATION

27 March 2017

A l’initiative de Médecins du Monde, une opposition au brevet sur le Sofosbuvir a été déposée devant l’Office européen des brevets (OEB), portant sur le composant de base qui permet de fabriquer le médicament. L’action est soutenue par trente ONG, dont treize sections de Médecins sans frontières en Europe ainsi que l’Alliance européenne pour la santé publique. 


PRAKSIS IS INVOLVED IN THE EUROPEAN PATENT APPLICATION AGAINST THE HEPATITIS C GRUG PATENT

YGEIA

27 March 2017

11 offices of Doctors of the World (Belgium, France, Germany, Greece, Luxembourg, Netherlands, Portugal, Spain, Sweden, Switzerland, UK), 13 Médecins Sans Frontières (Italy, Greece, France, Netherlands, Germany, Austria , Luxembourg, Sweden, Norway, Denmark, Czech Republic, the UK, Ireland) and 6 other organizations active in European countries ( European Public Health Alliance EPHA ], Just Treatment , Salud por Derecho, AIDES [France], PRAKSIS [Greece], Access to Medicines[Ireland]) are joining their voice in yet another dynamic initiative to access affordable medicines for citizens living in Europe.


LA PATENTE DE SAVOLDI, CUESTIONADA POR UNA TREINTENA DE ORGANIZACIONES

DIARIO FARMA

27 March 2017

A día de hoy, 30 organizaciones no gubernamentales y de la sociedad civil de 17 países europeos han presentado una oposición a la patente de Sovaldi (sofosbuvir) ante la Oficina Europea de Patentes (EPO). Entre ellas, 10 delegaciones de la red internacional de Médicos del Mundo, 13 de la red de Médicos sin Fronteras en Europa, cinco organizaciones sociales nacionales (entre ellas la española Salud por Derecho) y la Alianza Europea para la Salud Pública (EPHA).


EUROPEAN COMMISSION PUBLISHES LONG-AWAITED STUDY ON OFF-LABEL USE: INDUSTRY REACTS

LEXOLOGY

07 March 2017

The study, which was commissioned to the Dutch National Institute for Public Health and the Environment (Nivel) and the European Public Health Alliance (EPHA), was intended to gather information in order to identify the need for coordination of off-label use of medicines at the EU level, focusing on the one hand on – scientific – public health aspects, and on the other hand on the – legal – regulatory framework for the off-label use of medicines.


DE LA HTA A LA EMA: LOS ASUNTOS QUE VAN A MARCAR LA POLÍTICA FARMACÉUTICA DURANTE 2017

EL GLOBAL.NET

03 February 2017

La Alianza Europea por la Salud Pública (EPHA, por sus siglas en inglés), a través de su responsable para Acceso Universal y Medicamentos Asequibles, Yannis Natsis, ha señalado cuáles son los cinco asuntos más candentes que marcarán la política farmacéutica comunitaria hasta el 31 de diciembre.


THE REAL DIVIDES ON EUROPEAN HTA

APPLIED CLINICAL TRIALS

30 January 2017

The European Public Health Alliance says giving competence to EMA for HTA would be “counter-productive”, creating an “excessive and unchallenged concentration of power.” 


LA INDUSTRIA Y LA SOCIEDAD CONECTAN EN SU VISIÓN SOBRE EL FUTURO DE LA HTA EN EUROPA 

EL GLOBAL.NET

27 January 2017

“Las evaluaciones de las tecnologías sanitarias a menudo tienen un impacto directo sobre las decisiones de precios y reembolsos”, señala la EPHA. 


SOME MORE EQUAL THAN OTHERS

APPLIED CLINICAL TRIALS

24 January 2017

The concern about medicine prices as a component of the challenges is reflected in many contributions to the debate. Just at the end of January, the European Public Health Alliance spoke of “the access & innovation crises Europe faces primarily due to the exorbitant prices of medicines,” and told drug manufacturers that “they need to invest in real innovation and not towards a proliferation of me-too medicines.”


‘MONEY HAS TRUMPED THE ENVIRONMENT’ OVER EU-CANADA DEAL – CAMPAIGNERS

SPUTNIKNEWS.COM

13 January 2017

“The Committee has decided not to follow the progressive line marked by the Employment and Social Affairs (EMPL) Committee and to address citizens’ concerns. Obtaining a better deal for health and consumers is still possible, but the opportunities are beginning to thin out,” said Zoltán Massay-Kosubek, EPHA Policy Coordinator for Healthy Trade.


TRANSFORMING HEALTH CARE THROUGH DISRUPTIVE INNOVATION: WILL YOUR DATA CURE YOU?

POLITICO

12 January 2017

POLITICO recently gathered a group of Commission officials, researchers, health care professionals and industry representatives to ponder how Europe should approach the use of technology to improve health care.


GRECIA, INCHIESTA SU MAXIBUCO CREATO DA NOVARTIS. SPUNTA NOME GOVERNATORE BANCA CENTRALE

MONDOGRECO.NET

09 January 2017

Intanto Yannis Natsis, Policy Coordinator presso la European Public Health Alliance, ha dichiarato non solo che le accuse di corruzione dimostrano che l’industria farmaceutica ancora una volta abusa del suo strapotere ma che, nonostante la Grecia potrebbe essere descritta come un paese in bancarotta, numerosi medicinali con prezzi esorbitanti, soprattutto quelli oncologici, sono ancora pienamente rimborsati dallo Stato: con profitti fiume per le multinazionali.


GRECIA, INCHIESTA SU MAXIBUCO CREATO DA NOVARTIS. SPUNTA NOME GOVERNATORE BANCA CENTRALE

IL FATTO QUOTIDIANO

8 January 2017

Intanto Yannis Natsis, Policy Coordinator presso la European Public Health Alliance, ha dichiarato non solo che le accuse di corruzione dimostrano che l’industria farmaceutica ancora una volta abusa del suo strapotere ma che, nonostante la Grecia potrebbe essere descritta come un paese in bancarotta, numerosi medicinali con prezzi esorbitanti, soprattutto quelli oncologici, sono ancora pienamente rimborsati dallo Stato: con profitti fiume per le multinazionali.


NOVARTIS UNDER SCRUTINY FOR ALLEGED PHARMA SCANDAL IN GREECE

EURACTIV

5 January 2017

For Yannis Natsis, Policy Coordinator at the European Public Health Alliance, the bribery allegations do not come as a surprise and he doubts that this is a practice limited to Greece only.

Development by Simpl.

SUBSCRIBE TO OUR MAILING LIST

We publish our newsletter ten times a year to keep you informed about the latest news on public health in Europe. You can receive it directly in your mailbox.
First Name
Last Name
Email address
Secure and Spam free...